A detailed history of Channing Capital Management, LLC transactions in Medtronic PLC stock. As of the latest transaction made, Channing Capital Management, LLC holds 99,432 shares of MDT stock, worth $8.06 Million. This represents 0.24% of its overall portfolio holdings.

Number of Shares
99,432
Previous 85,844 15.83%
Holding current value
$8.06 Million
Previous $6.76 Million 32.49%
% of portfolio
0.24%
Previous 0.19%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$76.84 - $91.03 $1.04 Million - $1.24 Million
13,588 Added 15.83%
99,432 $8.95 Million
Q2 2024

Aug 14, 2024

BUY
$78.71 - $87.02 $983,402 - $1.09 Million
12,494 Added 17.03%
85,844 $6.76 Million
Q1 2024

May 15, 2024

SELL
$82.84 - $88.09 $571,678 - $607,909
-6,901 Reduced 8.6%
73,350 $6.39 Million
Q4 2023

Feb 06, 2024

BUY
$69.43 - $83.43 $384,086 - $461,534
5,532 Added 7.4%
80,251 $6.61 Million
Q3 2023

Nov 13, 2023

BUY
$78.22 - $90.4 $1,642 - $1,898
21 Added 0.03%
74,719 $5.85 Million
Q2 2023

Aug 11, 2023

SELL
$79.47 - $91.38 $1.05 Million - $1.21 Million
-13,261 Reduced 15.08%
74,698 $6.58 Million
Q1 2023

May 09, 2023

SELL
$76.72 - $87.58 $2.5 Million - $2.86 Million
-32,622 Reduced 27.05%
87,959 $7.09 Million
Q4 2022

Feb 14, 2023

BUY
$76.18 - $87.74 $1.86 Million - $2.14 Million
24,420 Added 25.39%
120,581 $9.37 Million
Q3 2022

Nov 08, 2022

BUY
$80.75 - $95.31 $410,452 - $484,460
5,083 Added 5.58%
96,161 $7.77 Million
Q2 2022

Aug 11, 2022

BUY
$87.4 - $113.09 $786,600 - $1.02 Million
9,000 Added 10.97%
91,078 $8.17 Million
Q1 2022

May 12, 2022

BUY
$100.58 - $112.38 $993,931 - $1.11 Million
9,882 Added 13.69%
82,078 $9.11 Million
Q4 2021

Feb 11, 2022

BUY
$99.53 - $127.75 $7.19 Million - $9.22 Million
72,196 New
72,196 $7.47 Million

Others Institutions Holding MDT

About Medtronic plc


  • Ticker MDT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,329,149,952
  • Market Cap $108B
  • Description
  • Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...
More about MDT
Track This Portfolio

Track Channing Capital Management, LLC Portfolio

Follow Channing Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Channing Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Channing Capital Management, LLC with notifications on news.